Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses reports Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
